Elekta AB Unsponsored American Depositary Receipt (EKTAY)
Market Closed
18 Jun, 20:00
OTC PINK OTC PINK Primary 
XMUN $
5. 03
-0.01
-0.1984%
$
1.92B Market Cap
19.91 P/E Ratio
0.27% Div Yield
1,500 Volume
0 Eps
$ 5.04
Previous Close Want to track EKTAY and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
EKTAY closed today lower at $5.03, a decrease of -0.1984% from yesterday's close, completing a monthly decrease of -13.7221% or -$0.8. Over the past 12 months, EKTAY stock lost -17.6759%.
EKTAY pays dividends to its shareholders, with the most recent payment made on Mar 26, 2026. The next estimated payment will be in In 3 months on Sep 26, 2026 for a total of $0.06496.
The last earnings report, released on May 27, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0.0211%, based on the last three reports.
Elekta AB Unsponsored American Depositary Receipt has completed 1 stock splits, with the recent split occurring on Sep 25, 2012.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on OTC PINK (USD).
Elekta AB (publ) (EKTAY) Analyst/Investor Day Transcript
Elekta AB (publ) (EKTAY) Analyst/Investor Day Transcript
Seekingalpha | 1 day ago
Elekta AB: Tricky, But With A Latent Upside
Elekta AB (publ) is rated Buy with a 56 SEK ($6 ADR) price target, reflecting a 15% annualized return potential at 15x P/E. EKTAY's historical premium is no longer justified due to persistent earnings misses, slow growth, and margin challenges, but current valuation now offers upside. Recent improvements include a 300 bps EBIT margin rise, 4.3% yield with a 79% payout ratio, and positive book-to-bill and cash flow trends.
Seekingalpha | 1 month ago
Elekta AB (publ) (EKTAY) Q3 2026 Earnings Call Transcript
Elekta AB (publ) (EKTAY) Q3 2026 Earnings Call Transcript
Seekingalpha | 3 months ago
Elekta AB Unsponsored American Depositary Receipt (EKTAY) FAQ
What is the stock price today?
The current price is $5.03.
On which exchange is it traded?
Elekta AB Unsponsored American Depositary Receipt is listed on OTC PINK.
What is its stock symbol?
The ticker symbol is EKTAY.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 0.27%.
What is its market cap?
As of today, the market cap is 1.92B.
Has Elekta AB Unsponsored American Depositary Receipt ever had a stock split?
Elekta AB Unsponsored American Depositary Receipt had 1 splits and the recent split was on Sep 25, 2012.
Elekta AB Unsponsored American Depositary Receipt Profile
| Electronic Equipment, Instruments & Components Industry | Information Technology Sector | Jakob Just-Bomholt CEO | OTC PINK Exchange | 28617Y101 CUSIP |
| SE Country | 4,541 Employees | 26 Sep 2025 Last Dividend | 25 Sep 2012 Last Split | - IPO Date |
Overview
Elekta AB (publ) is a global medical technology company that specializes in developing clinical solutions for the treatment of cancer and brain disorders. The company, incorporated in 1972 and based in Stockholm, Sweden, operates worldwide, providing a wide range of innovative products designed to improve patient outcomes. Elekta’s offerings encompass a variety of radiotherapy, radiosurgery, and brachytherapy systems, as well as software solutions for the effective management of cancer treatment workflows.
Products and Services
- Versa HD: A comprehensive solution for treating brain metastases, combining advanced radiation therapy technologies for precision and flexibility.
- Elekta Unity: Features real-time MR visualization, enabling clinicians to adapt radiation treatment in response to changes in tumor size, shape, and position.
- Elekta Harmony: A versatile linear accelerator designed for efficient and accurate radiation treatment across a wide range of cancer types.
- Elekta Infinity: Offers sophisticated treatment capabilities for a broad spectrum of patients, supporting simple to complex radiotherapy needs.
- Elekta Synergy: A digital accelerator that enhances image-guided radiation therapy (IGRT) through precise and adaptable treatment options.
- Elekta Studio: An integrated solution for image-guided brachytherapy, facilitating high precision in the treatment of various cancer types.
- ImagingRing: A mobile CT scanner that provides high-quality imaging to support precise treatment planning and delivery.
- Oncentra Brachy: A smart tool designed to streamline and facilitate repetitive tasks in brachytherapy planning.
- Venezia Applicator: Enables effective treatment of locally advanced cervical cancer, enhancing the precision and reach of therapy.
- Elekta Flexitron: An afterloader system that enables precise execution of brachytherapy workflows, ensuring accuracy in treatment delivery.
- Geneva: An applicator specifically designed for advanced cervical cancer treatment, promoting accuracy and patient comfort.
- Veterinary Radiation Therapy Products: Offers specialized radiation therapy solutions tailored for veterinary applications.
- Elekta Kaiku: A personalized cancer care platform, leveraging data analytics for tailored treatment planning and monitoring.
- Stereotactic Radiosurgery Solutions: Includes the Leksell Gamma Knife Icon and Perfexion for precise, personalized radiation treatment of brain disorders.
- Elekta Esprit: A new addition to the stereotactic radiosurgery portfolio, offering sophisticated capabilities for targeted brain therapies.
- Neurosurgery Products: Such as Leksell Vantage Stereotactic System and Leksell Stereotactic System, which facilitate minimally invasive neurosurgery with high precision.
Contact Information
Address: Kungstensgatan 18
Phone: 46 8 58 72 54 00
Website: https://www.elekta.com
